NCT02972125View on ClinicalTrials.gov

A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

Lacosamide (LCM) tablet

Treatment A: Single dose of Lacosamide (LCM) 100 mg tablet

DRUG

Lacosamide (LCM) dry syrup

Treatment B: Single dose of Lacosamide (LCM) 100 mg given as dry syrup

Trial Locations (1)

Unknown

Ep0059 001, London

All Listed Sponsors

lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT02972125 - A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects | Biotech Hunter | Biotech Hunter